Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Aug;66(8):1056-8.
doi: 10.1136/ard.2006.060368. Epub 2007 Jan 12.

Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout

Eliseo Pascual  1 , Francisca Sivera
Affiliations

Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout

Eliseo Pascual et al. Ann Rheum Dis. 2007 Aug.

Abstract

Objectives: To determine whether hypouricaemic treatment results in the disappearance of urate crystals from gouty joints and to define the time required.

Methods: In 18 patients with monosodium urate (MSU) crystal proven gout, and after the initiation of successful serum uric acid (SUA)-lowering treatment, an arthrocentesis of the asymptomatic signal joint (11 knees, 7 first metatarsophalangeal joints) was performed every 3 months to obtain a synovial fluid (SF) sample. The sample was then analysed for the presence of MSU crystals, and the number of crystals/400x field was noted. SUA levels and the duration of gout were also noted.

Results: MSU crystals disappeared from the SF of all 18 joints after reduction of SUA to normal levels. The time required for disappearance ranged from 3 to 33 months; disappearance time correlated with the duration of gout (r(s) = 0.71; p<0.01). The median number of MSU crystals in the SF samples before urate-lowering treatment was 7.5 (2.5-11) crystals/400x field, reducing to 3 (1-6.5) crystals/400x field (p<0.05) at 3 months. Crystal counts continued to decrease after 3 months.

Conclusions: In gout, reduction of SUA to normal levels results in disappearance of urate crystals from SF, requiring a longer time in those patients with gout of longer duration. This indicates that urate crystal deposition in joints is reversible. Normalisation of SUA levels results in a decrease in the concentration of MSU crystals in SF in the asymptomatic gouty joints. This may partially explain the reduced frequency of gouty attacks when a patient has been treated with SUA-lowering drugs.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

References

    1. Yü T ‐ F, Gutman A B. Principles of current management of primary gout. Am J Med Sci 1967254893–907. - PubMed
    1. Yü T ‐ F, Gutman A B. Mobilization of gouty tophi by protracted use of uricosuric agents. Am J Med 195111765–769. - PubMed
    1. Perez‐Ruiz F, Calabozo M, Pijoan J I, Herrero‐Beites A M, Ruibal A. Effect of urate‐lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 200247356–360. - PubMed
    1. Pascual E. Persistence of monosodium urate crystals, and low grade inflammation, in the synovial fluid of untreated gout. Arthritis Rheum 199134141–145. - PubMed
    1. Pascual E, Batlle‐Gualda E, Martínez A, Rosas J, Vela P. Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med 1999131756–759. - PubMed